辉瑞疫苗有效率逾九成 道指期货急升逾千四点 港股夜期高水逾六百点
辉瑞公司(PFE.US)和BioNTech SE(BNTX.US)共同开发的新冠肺炎疫苗,在以万计志愿者参与测试的研究中,有九成人可免疫,为迄今为止最令人鼓舞的进展。辉瑞股价在盘前交易时段现涨11.8%,报40.7美元。
消息刺激美股期货上升,道指期货现急升1,462点,报29,666。标普500期货现升126点,报3,627;纳指期货反覆微升3点,报12,078。
欧洲三大主要股市现升4.6%至5.6%。
恒指即月夜期现升639点,报26,670,高水654点,成交20,678张。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.